Maintaining an astronaut’s health during space travel is crucial. Multiple studies have observed various changes in the gut microbiome and physiological health.
Astronauts on board the International Space Station (ISS) had changes in the microbial communities in their gut, nose, and skin.
Additionally, immune system cell alterations have been observed in astronauts with changes in neutrophils, monocytes, and T-cells.
Probiotics blends help tackle these health issues caused during spaceflight by inhibiting pathogen adherence, enhancing epithelial barrier function by reducing permeability, and producing an anti-inflammatory effect.
When exposed to microgravity, probiotics blends demonstrated a shorter lag phase, faster growth, improved acid tolerance, and bile resistance.
A freeze-dried Lactobacillus casei strain Shirota capsule was tested for its stability on ISS for a month and has been shown to enhance innate immunity and balance intestinal microbiota.
The usage of freeze-dried spores of B. subtilis proves to be advantageous to long-term spaceflight because it qualifies for all the aspects tested for commercial probiotics under simulated conditions as it has an improved stability.
These results demonstrate a need to further study the effect of probiotics in simulated microgravity and spaceflight conditions.
These results may be useful to overcome the effects caused by gut microbiome dysbiosis and issues that might occur during spaceflight.
Article source:
Source of the featured image of the article:
Imagen de vecstock at Freepik